Jordan R. Plews

Jordan R. Plews, Ph.D., is Cofounder & Chief Executive Officer of ELEVAI Skincare. He has had leading roles in building teams, consulting, and advising on clinical development programs and product launches at various pharmaceutical companies including Pfizer, where he led the bioprocess development group and worked on skin cancer treatments and biologics.

Dr. Plews, whose research has been published in top-tier medical journals such as Nature Methods and the Journal of Cellular and Molecular Medicine, obtained his postdoctoral training at Stanford University. There, he conducted research and trained Ph.D. students. Following many years of research utilizing various types of stem cells to treat a variety of health issues, Dr. Plews co-founded Xytogen Biotech in 2015, a California-based cosmeceutical company developing next-generation topical, stem cell-based skin care solutions. Over five years, he led a team to build a fully-functioning stem cell culture laboratory and launched over five high-end products that generated multi-million dollars in top-line national sales.

Dr. Plews’ career spans biochemical engineering, molecular biology, and stem cell applications. He earned a Ph.D. and received first-class honors in the engineering doctorate program in Biochemical Engineering & Bioprocess Management at University College London.